This Is MS Multiple Sclerosis Community: Knowledge & Support

For me, the interesting part of the article is the update on the clinical trials. This seems like the best hope for a treatment for PPMS in the short-medium term.


"Dr. Stuve's study involves patients with primary progressive disease. Enrollment just finished, comprising 435 patients at 60 sites in the United States and Canada . Another study involving patients with relapsing-remitting disease is enrolling patients and is being by led by researchers at the University of California in San Francisco."

What trial phase is this in?

Phase II for both PPMS and RRMS trials, although it looks like the PP trials are slightly further along. I'm betting they'll start prescribing this for PP off-label pretty fast if the trial has decent results.